Two Sigma Securities, LLC Adamis Pharmaceuticals Corp Transaction History

Two Sigma Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.1 - $0.3 $334 - $1,002	-3,343 Reduced 11.95%	24,628 $2,000
Q4 2022 Feb 14, 2023	SELL	$0.14 - $0.22 $1,698 - $2,669	-12,135 Reduced 30.26%	27,971 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.24 - $0.54 $12,855 - $28,924	-53,563 Reduced 57.18%	40,106 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.34 - $0.57 $31,847 - $53,391	93,669 New	93,669 $47,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $12,598 - $16,721	-22,906 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.23 $13,056 - $28,174	22,906 New	22,906 $14,000
Q3 2018 Nov 14, 2018	SELL	$2.25 - $4.8 $31,396 - $66,979	-13,954 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.2 - $4.7 $44,652 - $65,583	13,954 New	13,954 $45,000
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $42,789 - $81,383	-16,780 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $58,730 - $94,807	16,780	16,780 $74,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.